Coccoid H. pylori: A key driver of recurrent infections and a target for novel therapies

球状幽门螺杆菌:复发感染的关键驱动因素和新型疗法的靶点

阅读:1

Abstract

Helicobacter pylori is a globally prevalent pathogen linked to gastritis, peptic ulcers, and gastric cancer, with over half the world's population infected as of recent estimates. While its helical form is well characterized for colonization and virulence, the bacterium's ability to transform into a coccoid morphology under stress conditions remains enigmatic. This review explores the role of the coccoid form in the recurrence of H. pylori infection, emphasizing its potential as a viable but non-culturable (VBNC) state that facilitates persistence, immune evasion, and reinfection. We highlight the novel role of type-I toxin-antitoxin (TA) systems, especially the AapA1/IsoA1 pair, in regulating the coccoid transformation. The AapA1/IsoA1 system facilitates the morphological shift to the coccoid form, which is resistant to conventional diagnostics and antibiotics. This immune evasion and antibiotic tolerance results in treatment failure and infection recurrence, even after apparent eradication. Targeting TA systems, alongside other factors, such as peptidoglycan remodeling, could enhance the efficacy of current therapies and reduce relapse rates, offering a pathway for more effective long-term management of H. pylori infections.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。